ReviewMarine drugs2017
Investigating the Biosynthesis of Natural Products from Marine Proteobacteria: A Survey of Molecules and Strategies.
Review in Marine drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.
- Pooled it
- Establishment of anmSystems · 2026Article
- Advances in tools, strategies, and applications of mining of microbial genomes for novel antimicrobials: a comprehensive review.Folia microbiologica · 2026Review
- The Cytotoxic Activity of Secondary Metabolites from Marine-DerivedMarine drugs · 2025Review
- The Metabolic Potential of the Human Lung Microbiome.Microorganisms · 2024Article
- Industrial and Pharmaceutical Applications of Microbial Diversity of Hypersaline Ecology from Lonar Soda Crater.Current pharmaceutical biotechnology · 2024Review
- Gut and Gill-Associated Microbiota of the Flatfish European Plaice (Marine drugs · 2022Article
- AntarcticFrontiers in microbiology · 2022Article
- Ancient Bacterial ClassInternational journal of molecular sciences · 2021Article
- In Silico Analysis of P450s and Their Role in Secondary Metabolism in the Bacterial ClassMolecules (Basel, Switzerland) · 2021Article
- Assessing the Diversity and Biomedical Potential of Microbes Associated With the Neptune's Cup Sponge,Frontiers in microbiology · 2021Article
- High Potential for Secondary Metabolite Production ofFrontiers in microbiology · 2021Article
- Genome Mining, Microbial Interactions, and Molecular Networking Reveals New Dibromoalterochromides from Strains ofMarine drugs · 2020Article
- Genome Mining as New Challenge in Natural Products Discovery.Marine drugs · 2020Review
- Diversity and Distribution of Bacteria Producing Known Secondary Metabolites.Microbial ecology · 2019Article
- Advances in microbial culturing conditions to activate silent biosynthetic gene clusters for novel metabolite production.Journal of industrial microbiology & biotechnology · 2019Review
- Individual Physiological Adaptations Enable Selected Bacterial Taxa To Prevail during Long-Term Incubations.Applied and environmental microbiology · 2019Article
- Bulbiferates A and B: Antibacterial Acetamidohydroxybenzoates from a Marine Proteobacterium,Journal of natural products · 2019Article
- Culturing marine bacteria from the genus Pseudoalteromonas on a cotton scaffold alters secondary metabolite production.MicrobiologyOpen · 2019Article
- Analysis of the Genome and Metabolome of Marine Myxobacteria Reveals High Potential for Biosynthesis of Novel Specialized Metabolites.Scientific reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The phylum proteobacteria contains a wide array of Gram-negative marine bacteria. With recent advances in genomic sequencing, genome analysis, and analytical chemistry techniques, a whole host of information is being revealed about the primary and secondary metabolism of marine proteobacteria. This has led to the discovery of a growing number of medically relevant natural products, including novel leads for the treatment of multidrug-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.